跳至主要内容
临床试验/NCT01467349
NCT01467349已完成不适用

Efficacy of Raltegravir in a Large Urban HIV Clinic Population in Milan (Efficacy of Raltegravir in a Large Urban HIV Clinic Setting)

Università Vita-Salute San Raffaele1 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2011年12月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
400
试验地点
1
主要终点
Real-Life

研究概览

简要总结

This will be a retrospective analysis of efficacy, safety and tolerability of raltegravir as part of an optimized therapy in a clinical setting.

Follow-up is calculated from the treatment initiation (with or without raltegravir) up to the date of discontinuation of the considered regimen or the date of last visit or the date of lost to follow-up, whichever came first.

The Aim of the study is to evaluate the efficacy and safety of raltegravir-containing regimens in a urban clinic setting.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects who received raltegravir and were previously exposed to NRTIs, NNRTIs, PIs, regardless of the stage of HIV disease at the start of the treatment.

排除标准

  • 未提供

结局指标

主要结局

Real-Life

时间窗: baseline and week 48

Primary endpoint is the proportion of patients with HIV-1 RNA\<50 copies/ml at weeks 48 after treatment initiation (baseline).

次要结局

  • Real-Life(baseline and week 48)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Elisabetta Carini

Professor Massimo Clementi

Università Vita-Salute San Raffaele

研究点 (1)

Loading locations...

相似试验